HK Stock Market Move | CGN POWER (01816) rose over 5%, with a year-on-year increase of 15.06% in net profit attributable to the parent company in the second quarter and a revenue growth of over 10%.
China General Nuclear Power (01816) rose over 5%. As of the time of publication, it increased by 5.29%, trading at HK$2.985, with a turnover of HK$76.2078 million.
CGN POWER (01816) rose over 5%. As of the time of writing, it was up 5.29% at HKD 2.985, with a transaction volume of HKD 76.2078 million.
In terms of news, CGN POWER announced its interim results for 2026, with operating revenue of approximately RMB 31.483 billion, a year-on-year decrease of 2.8%. The net profit attributable to shareholders of the parent company was about RMB 6.105 billion, reflecting a year-on-year increase of 2.7%. Looking at the second quarter alone, the company's quarterly main revenue was RMB 15.164 billion, up 11.79% year-on-year; the net profit attributable to the parent company for the quarter was RMB 3.364 billion, a year-on-year increase of 15.06%.
As of June 30, 2026, the group managed a total of 30 operational nuclear power units with an installed capacity of 34,248 megawatts, achieving a grid-connected electricity output of 109.597 billion kilowatt-hours, a year-on-year decrease of 3.32%. This output is equivalent to reducing carbon dioxide emissions by approximately 10.12677 million tons from coal-fired power generation. Among them, the subsidiaries generated a grid-connected electricity output of 87.254 billion kilowatt-hours, a year-on-year decrease of 2.25%.
Related Articles

HK Stock Market Move | XUNCE (03317) rose over 5% during trading, and Deutsche Bank maintains a "Buy" rating with a target price of HKD 351.

CICC: Maintain ASCENTAGE (06855) outperform industry rating, target price HKD 45.

HK Stock Market Move | SR MEDICAL (00108) surged nearly 7%, completing a cross-industry transformation in the past six months and clearly entering the new arena of AI-driven digital healthcare.
HK Stock Market Move | XUNCE (03317) rose over 5% during trading, and Deutsche Bank maintains a "Buy" rating with a target price of HKD 351.

CICC: Maintain ASCENTAGE (06855) outperform industry rating, target price HKD 45.

HK Stock Market Move | SR MEDICAL (00108) surged nearly 7%, completing a cross-industry transformation in the past six months and clearly entering the new arena of AI-driven digital healthcare.

RECOMMEND





